APA (7th ed.) Citation

T, K., DA, S., MZ, D., DA, T., & L, E. (2024). Benefit-Risk Assessment of mRNA COVID-19 Vaccines in Children Aged 6 Months to 4 Years in the Omicron Era. Journal of the Pediatric Infectious Diseases Society, 13(2), 129. https://doi.org/10.1093/jpids/piae002

Chicago Style (17th ed.) Citation

T, Kitano, Salmon DA, Dudley MZ, Thompson DA, and Engineer L. "Benefit-Risk Assessment of MRNA COVID-19 Vaccines in Children Aged 6 Months to 4 Years in the Omicron Era." Journal of the Pediatric Infectious Diseases Society 13, no. 2 (2024): 129. https://doi.org/10.1093/jpids/piae002.

MLA (9th ed.) Citation

T, Kitano, et al. "Benefit-Risk Assessment of MRNA COVID-19 Vaccines in Children Aged 6 Months to 4 Years in the Omicron Era." Journal of the Pediatric Infectious Diseases Society, vol. 13, no. 2, 2024, p. 129, https://doi.org/10.1093/jpids/piae002.